For anyone who truly doesn't know where to start when looking for a mini freezer, you can't go wrong with the Hotpoint's ...

Boston-based Vertex said late Wednesday it was acquiring Alpine for $65 a share in cash, or $4.9 billion, giving it access to the company’s product candidate for chronic kidney disease.

PORTLAND, Ore. (KOIN) — Just after 6:30 p.m. Thursday, a preliminary report of a 4.9 magnitude earthquake rattled parts of northern California. The USGS reported the quake happening just four ...

A new tram line worth £442 million in a European city is among the world’s most expensive but covers a distance of only 4.9 miles. The Uithoflijn tram, also known as the Utrecht Uithof tramline ...

Vertex Pharmaceuticals VRTX-0.27%decrease; red down pointing triangle has agreed to acquire Alpine Immune Sciences ALPN-0.06%decrease; red down pointing triangle for $4.9 billion in cash ...

Vertex Pharmaceuticals announced its biggest M&A play yet Wednesday evening, acquiring Alpine Immune Sciences for $4.9 billion. The deal was unanimously approved by the board of directors at both ...

opens new tab for about $4.9 billion in cash, gaining access to the biotech firm's treatment for an autoimmune disease of the kidney, the companies said on Wednesday. The deal values each share of ...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that is really flourishing, you can make more ...

Looking for an easy way to earn passive income? One Vanguard exchange-traded fund (ETF) pays a dividend yield of nearly 4.9%. ETFs offer a great way to invest in a large basket of stocks in one ...

Fixed asset investment grew 4.5 per cent against a year earlier in the quarter, boosted by a 9.9 per cent increase in manufacturing investment that was offset by a 9.5 per cent fall in property ...

Richmond Mutual Bancorporation's investment case relies on its above-average dividend yield compared to other regional banks. The bank's growth prospects and business diversification could be ...

Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion, the companies announced Wednesday. It is the largest ...